LINC00641 and prostate carcinoma: When further exploring the mechanism of LINC00641 in prostate cancer, it was found that miR-365a-3p was a downstream target of LINC00641 and miR-365a-3p was up-regulated in prostate cancer and negatively correlated with LINC00641.